HeyJaredMendelspod Podcast
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine. www.mendelspod.com
Part of Mendelspod Podcast. Follow the publication for all its platforms.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 17, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 9, 2026
Latest episodes
Jennifer Dionne Wants to Read the Whole Proteome Using Nanophotonics, i.e. Raman Spectroscopy (opens the original)
Read excerpt
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com Jennifer Dionne, Stanford physicist and co-founder of Pumpkinseed, joins us to talk about a radically different way of reading proteins. Pumpkinseed’s deSIPHR technology combines nanophotonics with Raman spectroscopy to detect the molecular vibrations of individual amino acids. The goal is de novo protein sequencing that can read not only the 20 canonical amino acids, but potentially the enormous alphabet created by
Katie Maloney, Partner at DeciBio Consulting, Sees an Inflection Point for Digital and Computational Pathology (opens the original)
Read excerpt
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com Digital technology has been promising to transform pathology for years. But the last year looks different. Roche paid roughly $1 billion for PathAI. Tempus acquired Paige. Other deals are adding to a sudden wave of consolidation. And AstraZeneca is developing a computational pathology algorithm for TROP2 that could become a companion diagnostic used to determine which patients receive a drug. DeciBio partner Katie M
Agilent and Oxford Nanopore Discuss Bringing Long Reads to the Clinic with a Customer (opens the original)
Read excerpt
Acute leukemia patients often wait days or even weeks for the full battery of molecular tests needed to guide treatment decisions. Dr. Parth Shah from Dartmouth believes long read sequencing can dramatically shorten that timeline. In this episode, Shah joins Agilent's Rita Shaknovich and Oxford Nanopore's Claire Attwooll to discuss some details of how long reads are beginning to move from research applications into routine clinical testing. Along the way, we explore the role of targeted enrichme
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.